Abstract
Rheumatoid arthritis (RA) is a systematic inflammatory and intractable disease, which progressively affects multiple joints. Recent findings strongly suggest a key role of WNT signaling in the disease initiation and progression. In this review, we discuss the role and possibility of treatment by targeting WNT signaling.
Keywords: WNT, rheumatoid arthritis, FRP, β-catenin, synovium, matrix metalloproteinase
Mini-Reviews in Medicinal Chemistry
Title: The Role of WNT in Rheumatoid Arthritis and its Therapeutic Implication
Volume: 9 Issue: 3
Author(s): Kazushi Imai, Tadashige Chiba, Genta Maeda and Masako Morikawa
Affiliation:
Keywords: WNT, rheumatoid arthritis, FRP, β-catenin, synovium, matrix metalloproteinase
Abstract: Rheumatoid arthritis (RA) is a systematic inflammatory and intractable disease, which progressively affects multiple joints. Recent findings strongly suggest a key role of WNT signaling in the disease initiation and progression. In this review, we discuss the role and possibility of treatment by targeting WNT signaling.
Export Options
About this article
Cite this article as:
Imai Kazushi, Chiba Tadashige, Maeda Genta and Morikawa Masako, The Role of WNT in Rheumatoid Arthritis and its Therapeutic Implication, Mini-Reviews in Medicinal Chemistry 2009; 9(3) . https://dx.doi.org/10.2174/1389557510909030318
DOI https://dx.doi.org/10.2174/1389557510909030318 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Editorial (Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine)
Current Pharmacogenomics and Personalized Medicine Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Current Drug Delivery miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis
Current Gene Therapy Cellular and Molecular Mechanisms Involved in the Action of Vitamin D Analogs Targeting Vitiligo Depigmentation
Current Drug Targets Electrochemical Immunosensors for Disease Detection and Diagnosis
Current Medicinal Chemistry T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Life or Death? A Physiogenomic Approach to Understand Individual Variation in Responses to Hemorrhagic Shock
Current Genomics Coal Mine Dust Lung Disease: The Silent Coal Mining Disaster
Current Respiratory Medicine Reviews Mean Platelet Volume: A Link Between Thrombosis and Inflammation?
Current Pharmaceutical Design Iontophoretic Mediated Intraarticular Delivery of Deformable Liposomes of Diclofenac Sodium
Current Drug Delivery The Therapeutic Potential of ADAM15
Current Pharmaceutical Design Editorial (Thematic Issue: Novel Agents in the Treatment of Osteoporosis and Its Complications)
Current Drug Targets Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition
Current Cancer Drug Targets Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets Chemokines and Chemokine Receptors as Targets in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy A Study on Leukemic and Non-small Cell Lung Cancer Efficacy of Novel Isoxazoles Synthesized by Microwave Irradiation
Letters in Drug Design & Discovery Editorial (Thematic Issue: Rheumatology: An Evolutionary force in Biologics)
Current Pharmaceutical Design Lymphadenopathy as a Prodrome for Systemic Lupus Erythematous
Current Rheumatology Reviews Carotid Intima Media Thickness and Beyond
Current Drug Targets - Cardiovascular & Hematological Disorders Objective Biomarkers or Symptom Scores for the Classification of Fibromyalgia Syndrome?
Current Rheumatology Reviews